Pharmacognosy intro
Artemisia vulgaris L. (Asteraceae), commonly known as common mugwort, cronewort, or wild wormwood, is a robust perennial herb native to temperate Europe, Asia, and North Africa, now naturalized globally. The aerial parts (leaves and flowering tops) constitute the primary medicinal material, harvested during the July through September flowering period. The genus Artemisia encompasses approximately 500 species, including A. absinthium (wormwood), A. annua (the artemisinin source that earned a Nobel Prize for antimalarial therapy), and A. dracunculus (tarragon). While mugwort shares the same genus as the artemisinin-producing species, it does not contain therapeutically significant artemisinin levels. The essential oil (0.1 to 0.4% yield) contains the GABA-A receptor antagonist thujone (alpha and beta isomers, up to approximately 20% of the oil), camphor (5 to 15%), 1,8-cineole (eucalyptol), germacrene D, sabinene, borneol, and bornyl acetate. Sesquiterpene lactones, principally vulgarin and psilostachyin, provide the characteristic bitter taste and serve as the primary digestive-stimulating compounds. The plant also contains flavonoids (quercetin, rutin, jaceidin), coumarins (scopoletin, aesculetin), and polyacetylenes in the roots. Mugwort's digestive mechanism operates through classical bitter receptor activation. Vulgarin and psilostachyin stimulate T2R bitter taste receptors on both tongue and gastrointestinal epithelium, triggering a vagal reflex that increases gastric acid, bile, and pancreatic enzyme secretion. This positions mugwort as a traditional amarum (bitter tonic). The essential oil fraction provides antispasmodic effects through smooth muscle relaxation in the GI tract and uterus, with calcium channel modulation proposed as the mechanism. Thujone acts as a GABA-A receptor antagonist, producing CNS excitation. At sub-toxic doses, this may account for mugwort's persistent cross-cultural reputation as an oneirogenic (dream-enhancing) herb, though no rigorous clinical evidence supports this claim. The emmenagogue (menstrual stimulant) property attributed to mugwort across multiple traditions likely involves thujone and camphor stimulation of uterine contractions. Clinical evidence for mugwort as an internal herbal medicine is limited compared to its cultural significance. Di Lorenzo et al. (2018, Journal of Food Science) documented a case of thujone poisoning from concentrated mugwort infusion, with serum thujone measured at 27.7 microg/mL and symptoms including seizures, rhabdomyolysis, and renal impairment. This case establishes the toxicity threshold. Systematic reviews exist for moxibustion (dried mugwort burned near acupuncture points), particularly for breech presentation correction at BL67, though this represents a TCM procedure rather than internal herbal medicine. Mugwort is strictly contraindicated in pregnancy due to uterine stimulant effects and in epilepsy because thujone lowers seizure threshold.